Chen Y, Wu T, Burnier JV. The potential of extracellular vesicle-derived nanosystems in precision oncology. Nanomedicine (Lond). 2025 Aug 25:1-4. doi: 10.1080/17435889.2025.2550232. Epub ahead of print. PMID: 40851532.

Tsering T, Nadeau A, Ghasemi M, Chen Y, Kienzle L, Dickinson K, Douanne N, Burnier JV. A new class of extracellular vesicles, Motile Vesicles (“MoVes”), carry whole genome DNA and are emitted during active cancer cell migration. Preprint

MacInnis C, Dickinson K, Efremov K, Coish J, de Nobrega M, Auchinleck J, Allain-Labelle I, Palmer A, Bird L, Leung SOA, Burnier JV. Reading the Room: A Joint Perspective From a Scientist- and Patient-Partnered Working Group on the Importance of Patient-Centered Language in the Dissemination of Cancer Research. J Clin Oncol. 2025 Jul 18:JCO2500186. doi: 10.1200/JCO-25-00186. Epub ahead of print. PMID: 40680240.

Nadeau A, Tsering T, Abdouh M, Kienzle L, Cleyle J, Taylor L, Douanne N, Taylor L, Dickinson K, Siegle PM, Burnier JV. Characterization of extracellular vesicle-associated DNA and proteins derived from organotropic metastatic breast cancer cells. J Exp Clin Cancer Res. 2025 May 23.

Dickinson K, Cloutier E, Burnier JV. Biomarkers in Uveal Melanoma: Current and Emerging Applications Clinical Ophthalmic Oncology. 2025 May 2.

Bartolomucci A, Nobrega M, Ferrier T, Dickinson K, Kaorey N, Nadeau A, Castillo A, Burnier JV. Circulating tumor DNA to monitor treatment response in solid tumors and advance precision oncology. NPJ Precis Oncol. 2025 Mar 24;9(1):84. doi: 10.1038/s41698-025-00876-y. PMID: 40122951.

López RR, Zouggari C, Chen Y, Tsering T, Dickinson K, Nadeau A, Bustamante P, Erzingatzian A, Bartolomucci A, Ferrier S, Douanne N, Mounier C, Stiharu I, Nerguizian V, Burnier JV. A synthetic model of bioinspired liposomes to study cancer-cell derived extracellular vesicles and their uptake by recipient cells. Sci Rep. 2025 Mar 11;15(1):8430. doi: 10.1038/s41598-025-91873-5. PMID: 40069225; PMCID: PMC11897354.

Chen Y, Douanne N, Wu T, Kaur I, Tsering T, Erzingatzian A, Nadeau A, Juncker D, Nerguizian V, Burnier JV. Leveraging Nature’s Nanocarriers: Translating Insights from Extracellular Vesicles to Biomimetic Synthetic Vesicles for Biomedical Applications. Sci Adv. 2025 Feb 28;11(9):eads5249. doi: 10.1126/sciadv.ads5249. Epub 2025 Feb 26. PMID: 40009680; PMCID: PMC11864201.

Chen Y, Jin E, Abdouh M, Bonneil É, Jimenez Cruz DA, Tsering T, Zhou Q, Fuentes-Rodriguez A, Bartolomucci A, Goyeneche A, Landreville S, Burnier MN, Burnier JV. Co-isolation of human donor eye cells and development of oncogene-mutated melanocytes to study uveal melanoma. BMC Biol. 2025 Jan 21;23(1):16. doi: 10.1186/s12915-025-02118-w. PMID: 39838458.

Kaorey N, Dickinson K, Agnihotram VR, Zeitouni A, Sadeghi N, Burnier JV. The role of ctDNA from liquid biopsy in predicting survival outcomes in HPV-negative head and neck cancer: A meta-analysis. Oral Oncol. 2024 Dec 31;161:107148. doi: 10.1016/j.oraloncology.2024.107148. Epub ahead of print. PMID: 39742703.

Tsering T, Nadeau A, Rak J, Burnier JV. Analyzing Extracellular Vesicle-associated DNA Using Transmission Electron Microscopy at the Single EV-level. Current Protocols. 2024 November. doi:10.1002/cpz1.70047

Ferrier ST, Li M, Burnier JV. Azacytidine treatment affects the methylation pattern of genomic and cell-free DNA in uveal melanoma cell lines. BMC Cancer. 2024;24(1):1299. Published 2024 Oct 21. doi:10.1186/s12885-024-13037-4

Tsering T, Nadeau A, Wu T, Dickinson K, Burnier JV. Extracellular vesicle-associated DNA: ten years since its discovery in human blood. Cell Death & Disease, 2024 September.

Bustamante P, Coblentz J, Mastromonaco C, Youhnovska E, Ito H, Proença RP, Fonseca C, Dickinson K, Marcotte E, MacDonald M, Toledo-Dias AB, Bergeron S, Goyeneche A, Schmidt Andujar RA, Tsering T, Laskaris A, Jin E, Nadeau A, Porraccio T, Burnier MN, Burnier JV. Comprehensive clinical imaging, histopathological analysis and liquid biopsy-based surveillance of human uveal melanoma in a prolonged rabbit xenograft model. Melanoma Res. 2024 Aug 1;34(4):285-295. doi: 10.1097/CMR.0000000000000964. Epub 2024 Jun 7. PMID: 38847739.

Dickinson K, Sharma A, Venkata Agnihotram RK, Altuntur S, Park M, Meterissian S, Burnier JV. Circulating Tumor DNA and Survival in Metastatic Breast Cancer. JAMA Network 2024 September.

Nadeau A, Burnier JV. With >1000 authors, the updated “Minimum Information for Studies of Extracellular Vesicles” (MISEV) promotes rigor, reproducibility, and transparency in the liquid biopsy field. J Liquid Biopsy. 2024 June.

Su X, Brassard A, Bartolomucci A, Dhoparee-Doomah I, Qiu Q, Tsering T, Rohanizadeh R, Koufos O, Giannias B, Bourdeau F, Feng L, Messina-Pacheco J, Leo S, Sangwan V, Quail D, Tankel J, Spicer J, Burnier JV, Bailey SD, Ferri L, Cools-Lartigue J. Tumour extracellular vesicles induce neutrophil extracellular traps to promote lymph node metastasis. J Extracell Vesicles. 2023 Aug;12(8):e12341. doi: 10.1002/jev2.12341. PMID: 37563798.

Ferrier ST, Tsering T, Sadeghi N, Zeitouni A, Burnier JV Blood and saliva-derived ctDNA is a marker of residual disease after treatment and correlates with recurrence in human papillomavirus-associated head and neck cancer. Cancer Med. 2023 Aug 1. doi: 10.1002/cam4.6191. Epub ahead of print. PMID: 37526056.

Been T, Alakhtar B, Traboulsi H, Tsering T, Bartolomucci A, Heimbach N, Paoli S, Burnier J, Mann KK, Eidelman DH, Baglole CJ. Chronic low-level JUUL aerosol exposure causes pulmonary immunologic, transcriptomic, and proteomic changes. FASEB J. 2023 Feb;37(2):e22732. doi: 10.1096/fj.202201392R. PMID: 36694994.

Tsering T, Li M, Chen Y, Nadeau A, Laskaris A, Abdouh M, Bustamante P, Burnier JV. EV-ADD, a database for EV-associated DNA in human liquid biopsy samples. J Extracell Vesicles. 2022 Oct;11(10):e12270. doi: 10.1002/jev2.12270. PMID: 36271888.

Pessuti CL, Costa DF, Ribeiro KS, Abdouh M, Tsering T, Nascimento H, Commodaro AG, Marcos AAA, Torrecilhas AC, Belfort RN, Belfort R Jr, Burnier JV. Characterization of extracellular vesicles isolated from different liquid biopsies of uveal melanoma patients J Circ Biomark. 2022 Jun 27;11:36-47. doi: 10.33393/jcb.2022.2370. PMID: 35784590; PMCID: PMC9238429.

Abdouh M, Lu M, Chen Y, Goyeneche AA, Burnier JV, Burnier MN. Filtering blue light mitigates the deleterious effects induced by the oxidative stress in human retinal pigment epithelial cells. Experimental Eye Research 2022 Feb 5; doi: 10.1016/j.exer.2022.108978.

Alvarez PB, Laskaris A, Goyeneche AA, Chen Y, Telleria CM, Burnier JV. Anticancer effects of mifepristone on human uveal melanoma cells. Cancer Cell Int. 2021 Nov 17;21(1):607. doi: 10.1186/s12935-021-02306-y. PMID: 34789240; PMCID: PMC8597220.

López RR, Sánchez LM, Alazzam A, Burnier JV, Stiharu I, Nerguizian V. Numerical and Experimental Validation of Mixing Efficiency in Periodic Disturbance Mixers Micromachines (Basel). 2021 Sep 14;12(9):1102. doi: 10.3390/mi12091102. PMID: 34577745; PMCID: PMC8469598.

López RR, Ocampo I, Font de Rubinat PG, Sánchez LM, Alazzam A, Tsering T, Bergeron KF, Camacho-Léon S, Burnier JV, Mounier C, Stiharu I, Nerguizian V. Parametric Study of the Factors Influencing Liposome Physicochemical Characteristics in a Periodic Disturbance Mixer. Langmuir. 2021 Jul 7. doi: 10.1021/acs.langmuir.1c01005. Epub ahead of print. PMID: 34232664.

Bustamante P, Tsering T, Coblentz J, Mastromonaco C, Abdouh M, Fonseca C, Proença RP, Blanchard N, Dugé CL, Andujar RAS, Youhnovska E, Burnier MN, Callejo SA, Burnier JV. Circulating tumor DNA tracking through driver mutations as a liquid biopsy-based biomarker for uveal melanoma. J Exp Clin Cancer Res. 2021 Jun 16;40(1):196. doi: 10.1186/s13046-021-01984-w. PMID: 34134723.

López RR, G Font de Rubinat P, Sánchez LM, Tsering T, Alazzam A, Bergeron KF, Mounier C, Burnier JV, Stiharu I, Nerguizian V. The effect of different organic solvents in liposome properties produced in a periodic disturbance mixer: Transcutol®, a potential organic solvent replacement. Colloids Surf B Biointerfaces. 2021 Feb;198:111447. doi: 10.1016/j.colsurfb.2020.111447. Epub 2020 Nov 4. PMID: 33223347.

Ferrier ST, Burnier JV. Novel Methylation Patterns Predict Outcome in Uveal Melanoma. Life (Basel). 2020 Oct 20;10(10):E248. doi: 10.3390/life10100248. PMID: 33092094.

Tsering, T.; Laskaris, A.; Abdouh, M.; Bustamante, P.; Parent, S.; Jin, E.; Ferrier, S.T.; Arena, G.; Burnier, J.V. Uveal Melanoma-Derived Extracellular Vesicles Display Transforming Potential and Carry Protein Cargo Involved in Metastatic Niche Preparation. Cancers 2020, 12, 2923.

Jin E, Burnier JV. Liquid Biopsy in Uveal Melanoma: Are We There Yet?. Ocul Oncol Pathol 2020. doi: 10.1159/000508613

Bustamante P, Piquet L, Landreville S, Burnier JV. Uveal melanoma pathobiology: Metastasis to the liver. [published online ahead of print, 2020 May 22]. Semin Cancer Biol. 2020;S1044-579X(20)30099-7. doi:10.1016/j.semcancer.2020.05.003

Bustamante P, Miyamoto D, Goyeneche A, et al. Beta‐blockers exert potent anti‐tumor effects in cutaneous and uveal melanoma. Cancer Med. 2019;8(17):7265-7277. doi:10.1002/cam4.2594